Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease

Publication date: Available online 26 June 2017 Source:Journal of Microbiology, Immunology and Infection Author(s): Kazufumi Takamatsu, Satoshi Marumo, Motonari Fukui, Atsuko Hata We retrospectively analyzed data of 38 elderly patients, each with an underlying disease, to evaluate peramivir safety and efficacy. Six patients (15.8%) experienced adverse events, all tolerated. Median time from administration until the return to normal temperatures was 31.5 hr (95% CI: 22.4–40.6). Results confirm intravenous peramivir’s usefulness.
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research